Company intelligence
InsightRX
Maximize therapeutic success with precision medicine
Hospitals and Health Care
San Francisco, US
32 employees
Founded 2015
2 public signals
About InsightRX
InsightRX empowers life science and provider healthcare organizations to individualize treatment from clinical development to the point of care.
Verified activity
Signals from InsightRX
2 published signals
Research & Knowledge
InsightRX co-founder Dr. Ron Keizer co-authored a systematic review in pharmacokinetic variability in 21 studies of risankizumab, guselkumab, tildrakizumab, and mirikizumab, finding that PK has been characterized mostly in healthy subjects rather than in patients being treated.
Reported by InsightRX
Presence & Recognition
InsightRX is presenting its approach to pharmacometrics at ACoP 2026 on Sunday, October 11.
Reported by InsightRX